J Chabot

Cellular Imaging Predictions of Clinical Drug-Induced Liver Injury

Jinghai J. Xu, Peter Henstock, Margaret C. Dunn et al. · Toxicological Sciences · 2008 · 485 citations · Full text

A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects

Saswata Talukdar, Yingjiang Zhou, Dongmei Li et al. · Cell Metabolism · 2016 · 477 citations · Full text

Obesity, Metabolic Syndrome, Long-acting Fgf21 Molecule +12

Probing polymerization forces by using actin-propelled lipid vesicles

Arpita Upadhyaya, J Chabot, A P Andreeva et al. · Proceedings of the National Academy of Sciences · 2003 · 191 citations · Full text

Membrane Structure, Osmotic Pressure, Polymerization Forces +15

Increasing Serum Half-life and Extending Cholesterol Lowering in Vivo by Engineering Antibody with pH-sensitive Binding to PCSK9

Javier Chaparro‐Riggers, Liang Hong, Rachel M. DeVay et al. · Journal of Biological Chemistry · 2012 · 164 citations · Full text

Once‐weekly administration of a long‐acting fibroblast growth factor 21 analogue modulates lipids, bone turnover markers, blood pressure and body weight differently in obese people with hypertriglyceridaemia and in non‐human primates

Albert M. Kim, Veena Somayaji, Jennifer Dong et al. · Diabetes Obesity and Metabolism · 2017 · 136 citations